Home / Recalls / Medaus, Inc. / D-1189-2016

D-1189-2016 Class II Terminated

Recalled by Medaus, Inc. — Birmingham, AL

Recall Details

Product Type
Drugs
Report Date
July 20, 2016
Initiation Date
May 13, 2016
Termination Date
June 16, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1000 mL in Vials

Product Description

HYDROGEN PEROXIDE 3% (PF), 5ML Vials, MEDAUS PHARMACY

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

U.S. Nationwide, Japan, and New Zealand.

Code Information

Lot #: 160112-35, BUD: 07/10/16

Other recalls by Medaus, Inc.

  • D-1213-2016 Class II — MANGANESE SO4 0.1MG/ML (PF), In a) 2MLVials and b) 10ML Vials, MEDAUS PHARMACY (May 13, 2016)
  • D-1167-2016 Class II — B-COMPLEX #3 (PF), B1-100MG, B2-2-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 2ML Vial (May 13, 2016)
  • D-1175-2016 Class II — B-COMPLEX W/METHYL B12/LIDO W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3- (May 13, 2016)
  • D-1238-2016 Class II — SELENIUM 200MCG/ML (PF), 10ML Vials, MEDAUS PHARMACY (May 13, 2016)
  • D-1206-2016 Class II — LIPO-INJECTION W/METHYL B12 1 MG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG (May 13, 2016)
  • D-1200-2016 Class II — LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY (May 13, 2016)
  • D-1220-2016 Class II — M.I.C. 25/50/50 (PF) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50MG/ML, In 2ML (May 13, 2016)
  • D-1222-2016 Class II — M.I.C B-COMPLEX PREMIX W/HYDROXY B12 W/PRES. (BENZALKONIUM 0.01%) HYDROXY B12 (May 13, 2016)
  • D-1169-2016 Class II — B-COMPLEX (LIEBERMAN) IN NACL 0.9% (PF), B1-12.5MG, B2-5-PO4-10MG, B3-12.5MG, B5 (May 13, 2016)
  • D-1188-2016 Class II — HYALURONIDASE 500U/ML(PF), 3ML Vials, MEDAUS PHARMACY (May 13, 2016)